Abstract

BackgroundIn acutely injured lungs, massively recruited polymorphonuclear neutrophils (PMNs) secrete abnormally neutrophil elastase (NE). Active NE creates a localized proteolytic environment where various host molecules are degraded leading to impairment of tissue homeostasis. Among the hallmarks of neutrophil-rich pathologies is a disrupted epithelium characterized by the loss of cell-cell adhesion and integrity. Epithelial-cadherin (E-cad) represents one of the most important intercellular junction proteins. E-cad exhibits various functions including its role in maintenance of tissue integrity. While much interest has focused on the expression and role of E-cad in different physio- and physiopathological states, proteolytic degradation of this structural molecule and ensuing potential consequences on host lung tissue injury are not completely understood.MethodsNE capacity to cleave E-cad was determined in cell-free and lung epithelial cell culture systems. The impact of such cleavage on epithelial monolayer integrity was then investigated. Using mice deficient in NE in a clinically relevant experimental model of acute pneumonia, we examined whether degraded E-cad is associated with lung inflammation and injury and whether NE contributes to E-cad cleavage. Finally, we checked for the presence of both degraded E-cad and NE in bronchoalveolar lavage samples obtained from patients with exacerbated COPD, a clinical manifestation characterised by a neutrophilic inflammatory response.ResultsWe show that NE is capable of degrading E-cad in vitro and in cultured cells. NE-mediated degradation of E-cad was accompanied with loss of epithelial monolayer integrity. Our in vivo findings provide evidence that NE contributes to E-cad cleavage that is concomitant with lung inflammation and injury. Importantly, we observed that the presence of degraded E-cad coincided with the detection of NE in diseased human lungs.ConclusionsActive NE has the capacity to cleave E-cad and interfere with its cell-cell adhesion function. These data suggest a mechanism by which unchecked NE participates potentially to the pathogenesis of neutrophil-rich lung inflammatory and tissue-destructive diseases.Electronic supplementary materialThe online version of this article (doi:10.1186/s12931-016-0449-x) contains supplementary material, which is available to authorized users.

Highlights

  • In acutely injured lungs, massively recruited polymorphonuclear neutrophils (PMNs) secrete abnormally neutrophil elastase (NE)

  • In order to determine the potential relevance of our findings to human lung diseases, we examined whether degraded E-cad coincides with the presence of active NE in bronchoalveolar lavage samples obtained from patients with exacerbated chronic obstructive pulmonary diseases (COPD), a clinical condition characterized by a neutrophilic inflammatory response

  • Recombinant human secretory leukocyte proteinase inhibitor (SLPI) and polyclonal rabbit antibody for mouse extracellular E-Cadherin domain were from R&D Systems Europe

Read more

Summary

Introduction

Massively recruited polymorphonuclear neutrophils (PMNs) secrete abnormally neutrophil elastase (NE). While much interest has focused on the expression and role of E-cad in different physioand physiopathological states, proteolytic degradation of this structural molecule and ensuing potential consequences on host lung tissue injury are not completely understood. To protect itself against various infectious or toxic agents, the lung relies on different mechanisms Among these latter, the epithelium and resident macrophages are considered as the first lines of lung tissue protection. With respect to the epithelium, this cell lining participates in mounting an appropriate inflammatory response against insulting agents but acts primarily as a. When these “sentinel” lines are breached, neutrophils are called in.

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call